Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Higa

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The West Virginia Medical Journal|June 1, 1993
The chemohormonal therapy of metastatic melanoma: possible benefit of tamoxifenE B Crowell, G M Higa
Clinical Pharmacy|December 1, 1987
Alterations in aminoglycoside pharmacokinetics in patients with cancerG M Higa, W E Murray
The Annals of Pharmacotherapy|October 30, 1998
Doxorubicin dosage guidelines in a patient with hyperbilirubinemia of Gilbert's syndromeM J Cupp, G M Higa
Pharmacotherapy|December 17, 1997
Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of literatureG M Higa, N AlKhouri, M L Auber
Pharmacotherapy|January 23, 1999
Pharmacodynamic profile of prolonged etoposide administration in patients with small cell lung cancer and non-Hodgkin's lymphomaG M Higa, M A Sarkar, R F DeVore
The Annals of Pharmacotherapy|February 1, 1995
Severe, disabling neurologic toxicity following cisplatin retreatmentG M Higa, T C Wise, E B Crowell
Cancer|October 15, 1991
The use of prophylactic eye drops during high-dose cytosine arabinoside therapyG M Higa, J P Gockerman, A L Hunt, et al.
Pharmacotherapy|February 20, 1998
Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administrationG M Higa, R F DeVore, M L Auber, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The West Virginia Medical Journal|June 1, 1993
The chemohormonal therapy of metastatic melanoma: possible benefit of tamoxifenE B Crowell, G M Higa
Clinical Pharmacy|December 1, 1987
Alterations in aminoglycoside pharmacokinetics in patients with cancerG M Higa, W E Murray
The Annals of Pharmacotherapy|October 30, 1998
Doxorubicin dosage guidelines in a patient with hyperbilirubinemia of Gilbert's syndromeM J Cupp, G M Higa
Pharmacotherapy|December 17, 1997
Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of literatureG M Higa, N AlKhouri, M L Auber
Pharmacotherapy|January 23, 1999
Pharmacodynamic profile of prolonged etoposide administration in patients with small cell lung cancer and non-Hodgkin's lymphomaG M Higa, M A Sarkar, R F DeVore
The Annals of Pharmacotherapy|February 1, 1995
Severe, disabling neurologic toxicity following cisplatin retreatmentG M Higa, T C Wise, E B Crowell
Cancer|October 15, 1991
The use of prophylactic eye drops during high-dose cytosine arabinoside therapyG M Higa, J P Gockerman, A L Hunt, et al.
Pharmacotherapy|February 20, 1998
Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administrationG M Higa, R F DeVore, M L Auber, et al.
Pageof 2